# US 2003/0078280 A1 · Macroheterocylic compounds useful as kinase inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0078280 A1
- Document ID: US20030078280A1
- Status: Published application
- Kind: A1
- Application number: 10/008,982
- Filed: 2001-12-06
- Published: 2003-04-24
- Earliest claimed: 2000-12-08
- Assignees: Ortho-McNeil Pharmaceutical, Inc.
- Inventors: Gee-Hong Kuo; Han-Cheng Zhang; Catherine Prouty; Alan DeAngelis; Peter Connolly; William V. Murray; Lan Shen; Bruce Conway; Keith Demarest; Chandra R. Shah; Bruce E. Maryanoff; Kimberly B. White
- Web page: https://patentgrep.com/patent/US20030078280A1

## CPC

- C07D 471/22: in which the condensed systems contains four or more hetero rings
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/04: Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 11/06: Antiasthmatics
- A61P 13/12: of the kidneys
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/06: Antipsoriatics
- A61P 17/14: for baldness or alopecia
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/02: for peripheral neuropathies
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/24: Antidepressants
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/18: for HIV
- A61P 35/00: Antineoplastic agents
- A61P 37/02: Immunomodulators
- A61P 37/04: Immunostimulants
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 487/22: in which the condensed system contains four or more hetero rings
- C07D 498/22: in which the condensed system contains four or more hetero rings
- C07D 515/22: in which the condensed system contains four or more hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention is directed to macroheterocyclic compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

## Claims

### Claim 1

A compound of Formula (I):
44
wherein
A and E are independently selected from the group consisting of a hydrogen substituted carbon atom and a nitrogen atom; wherein
45
is independently selected from the group consisting of 1H-indole, 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 1H-indazole;
Z is selected from O or dihydro; wherein when Z is dihydro, each hydrogen atom is attached by a single bond;
R4 and R5 are independently selected from C1-8alkyl, C2-8alkenyl and C2-8alkynyl, wherein R4 and R5 are optionally substituted with oxo;
R2 is selected from the group consisting of —C1-8alkyl-, —C2-8alkenyl-, —C2-8alkynyl-, —O—(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)-(C1-8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl, heterocyclyl, aryl, heteroaryl (wherein cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy((C1-8))alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo), —(O—(CH2)1-6)0-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)0-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR6—, —NR6—C(O)—, —C(O)—NR6—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)(06-C(O)—(CH2)0-6—NR7—, —N—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S—, —NR6—(CH2)1-6—S—(CH2)1-6—NR7— and —SO2— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, (C1-8)alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo));
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —C2-8alkynyl-, —O—(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)—(C1-8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of Calkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl (wherein cycloalkyl is optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), —(O—(CH2)1-6)1-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)1-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)-6-NR7—(CH2)1-6—NR8—, —NR9—C(O)—, —C(O)—NR9—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S— and —NR6—(CH2)1-6—S—(CH2)1-6—NR7— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo); and, wherein R8 is selected from the group consisting of C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo)); and,
R1 and R3 are independently selected from the group consisting of hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl (wherein alkyl, alkenyl and alkynyl are optionally substituted with a substituent selected from the group consisting of C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), (halo)1-3, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo), C1-8alkoxy, C1-8alkoxycarbonyl, (halo)1-3(C1-8)alkoxy, C1-8alkylthio, aryl, heteroaryl (wherein aryl and heteroaryl are optionally substituted with a substituent selected from the group consisting of C1-8alkyl, C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), cyano, halogen, hydroxy and nitro; and pharmaceutically acceptable salts thereof.

### Claim 2 (depends on 1)

The compound of claim 1 wherein R4 and R5 are independently selected from C1-6alkyl, C2-6alkenyl and C2-6alkynyl optionally substituted with oxo.

### Claim 3 (depends on 1)

The compound of claim 1 wherein R4 and R5 are independently selected from C1-6alkyl, C2-6alkenyl and C2-6alkynyl.

### Claim 4 (depends on 1)

The compound of claim 1 wherein R4 and R5 are independently selected from C1-6alkyl.

### Claim 5 (depends on 1)

The compound of claim 1 wherein R2 is selected from the group consisting of —C1-8alkyl-, —C2-4alkenyl-, —C2-4alkynyl-, —O—(C1-4)alkyl-O—, —O—(C2-4)alkenyl-O—, —O—(C2-4)alkynyl-O—, —C(O)—(C1-4)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, —C(O)O—(C1-4)alkyl, —C1-4alkyl-C(O)O—(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy, hydroxy(C1-4)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-4)alkyl, aryl(C1-4)alkyl, heteroaryl(C1-4)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo), 3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl, heterocyclyl, aryl, heteroaryl (wherein cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein heterocyclyl is optionally substituted with oxo), —(O—(CH2)1-6)0-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)0-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR6—C(O)—, —C(O)—NR6—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S—, —NR6—(CH2)1-6—S—(CH2)1-6—NR7— and —SO2— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-4alkyl, C1-4alkoxy(C1-4)alkyl, carboxyl(C1-4)alkyl, amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-4)alkyl, heterocyclyl(C1-4)alkyl, aryl(C1-4)alkyl and heteroaryl(C1-4)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein heterocyclyl is optionally substituted with oxo));
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —C2-4alkynyl-, —O—(C1-4)alkyl-O—, —O—(C2-4)alkenyl-O—, —O—(C2-4)alkynyl-O—, —C(O)—(C1-4)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, —C(O)O—(C1-4)alkyl, —C1-4alkyl-C(O)O—(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy, hydroxy(C1-4)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-4)alkyl, aryl(C1-4)alkyl, heteroaryl(C1-4)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl (wherein cycloalkyl is optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl), —(O—(CH2)1-6)1-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)1-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR9—C(O)—, —C(O)—NR9—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S— and —NR6—(CH2)1-6—S—(CH2)1-6—NR7— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-4alkyl, C1-4alkoxy(C1-4)alkyl, carboxyl(C1-4)alkyl, amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-4)alkyl, heterocyclyl(C1-4)alkyl, aryl(C1-4)alkyl and heteroaryl(C1-4)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein heterocyclyl is optionally substituted with oxo); and, wherein R9 is selected from the group consisting of C1-4alkyl, C1-4alkoxy(C1-4)alkyl, carboxyl(C1-4)alkyl, amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-4)alkyl, heterocyclyl(C1-4)alkyl, aryl(C1-4)alkyl and heteroaryl(C1-4)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-4alkyl, C1-4alkoxy, C1-4alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl; and, wherein heterocyclyl is optionally substituted with oxo)).

### Claim 6 (depends on 1)

The compound of claim 1 wherein R2 is selected from the group consisting of —C1-8alkyl-(optionally substituted with one to three substituents independently selected from the group consisting of halogen, hydroxy and oxo); aryl, heteroaryl, —(O—(CH2)1-6)0-5—O—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—S—(CH2)1-6—O— and —NR6— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-4alkyl and C1-4alkoxy(C1-4)alkyl);
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —(O—(CH2)1-6)1-5—O—, —(O—(CH2)1-6)1-5—NR6—, —O—(CH2)1-6—NR6—(CH2)6—O— and —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-4alkyl and hydroxy(C1-4)alkyl).

### Claim 7 (depends on 1)

The compound of claim 1 wherein R2 is selected from the group consisting of —C1-8alkyl-(optionally substituted with one to two substituents independently selected from the group consisting of halogen, hydroxy and oxo); phenyl, pyridinyl, —(O—(CH2)2)1-4—O—, —O—(CH2)2—N—(CH2)2—O—, —O—(CH2)2—S—(CH2)2—O— and —NR6— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-3alkyl and C1-2alkoxy(C1-2)alkyl);
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —(O—(CH2)2)1-4—O—, —(O—(CH2)2)2—NR6—, —O—(CH2)2—NR6—(CH2)2—O— and —NR6—(CH2)2—NR7—(CH2)2—NR5— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-3alkyl and hydroxy(C1-2)alkyl).

### Claim 8 (depends on 1)

The compound of claim 1 wherein R1 and R3 are independently selected from the group consisting of hydrogen, C1-4alkyl, C2-4alkenyl, C2-4alkynyl (wherein alkyl, alkenyl and alkynyl are optionally substituted with a substituent selected from the group consisting of C1-4alkoxy, alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), (halo)1-3, (halo)1-3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy, hydroxy(C1-4)alkyl and oxo), C1-4alkoxy, C1-4alkoxycarbonyl, (halo)1-3(C1-4)alkoxy, C1-4alkylthio, aryl, heteroaryl (wherein aryl and heteroaryl are optionally substituted with a substituent selected from the group consisting of C1-4alkyl, C1-4alkoxy, alkoxy(C1-4)alkyl, carboxyl, carboxyl(C1-4)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-4)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo), 3(C1-4)alkyl, (halo)1-3(C1-4)alkoxy, hydroxy and hydroxy(C1-4)alkyl), amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), cyano, halogen, hydroxy and nitro.

### Claim 9 (depends on 1)

The compound of claim 1 wherein R1 and R3 are independently selected from the group consisting of hydrogen, C1-4alkyl (optionally substituted with a substituent selected from the group consisting of C1-4alkoxy, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), (halo)1-3, hydroxy and oxo), C1-4alkoxy, C1-4alkoxycarbonyl, (halo)1-3(C1-4)alkoxy, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, hydroxy and nitro.

### Claim 10 (depends on 1)

The compound of claim 1 wherein R1 and R3 are hydrogen.

### Claim 11 (depends on 1)

The compound of claim 1 wherein a compound of Formula (I) is selected from a compound of Formula (Iaa):
46
wherein
A and E are independently selected from the group consisting of a hydrogen substituted carbon atom and a nitrogen atom; wherein
47
is independently selected from the group consisting of 1H-indole, 1H-pyrrolo[2,3-b]pyridine and 1H-indazole;
R4 and R5 are independently selected from C1-8alkyl, C2-8alkenyl and C2-8alkynyl optionally substituted with oxo;
R2 is selected from the group consisting of —C1-8alkyl-, —C2-8alkenyl-, —C2-8alkynyl-, —O—(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)—(C1-8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo), 3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl, heterocyclyl, aryl, heteroaryl (wherein cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo), —(O—(CH2)1-6)0-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)0-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—N-6-, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—, —N—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR6—C(O)—, —C(O)—NR6—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S—, —NR6—(CH2)1-6—S—(CH2)1-6—NR7— and —SO2— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo));
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —C2-8alkynyl-, —O—(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)—(C8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl (wherein cycloalkyl is optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3((C1-8))alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), —(O—(CH2)1-6)1-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)1-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR9—C(O)—, —C(O)—NR9—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —N—C(NR7)—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S— and —NR6—(CH2)1-6—S—(CH2)1-6—NR7— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo); and, wherein R8 is selected from the group consisting of C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, (C1-8)alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo)); and,
R1 and R3 are independently selected from the group consisting of hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl (wherein alkyl, alkenyl and alkynyl are optionally substituted with a substituent selected from the group consisting of C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent 9independently selected from the group consisting of hydrogen and C1-4alkyl), (halo)1-3, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo), C1-8alkoxy, C1-8alkoxycarbonyl, (halo)1-3(C1-8)alkoxy, C1-8alkylthio, aryl, heteroaryl (wherein aryl and heteroaryl are optionally substituted with a substituent selected from the group consisting of C1-8alkyl, C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), cyano, halogen, hydroxy and nitro;
and pharmaceutically acceptable salts thereof.

### Claim 12 (depends on 1)

The compound of claim 1 wherein a compound of Formula (I) is selected from the group consisting of:
48
wherein
R4 and R5 are independently selected from C1-8alkyl, C2-8alkenyl and C2-8alkynyl optionally substituted with oxo;
R2 is selected from the group consisting of-C1-8alkyl-, —C2-8alkenyl-, —C2-8alkynyl-, —O—(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)—(C1-8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-8alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl, heterocyclyl, aryl, heteroaryl (wherein cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted with one to four substituents independently selected from the group consisting of CQ alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo), —(O—(CH2)1-6)0-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)0-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —NR6—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR6—C(O)—, —C(O)—NR6—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —NR6—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S—, —NR6—(CH2)1-6—S—(CH2)1-6—NR7— and —SO2— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo));
with the proviso that, if A and E are selected from a hydrogen substituted carbon atom, then R2 is selected from the group consisting of —C2-8alkynyl-, —O-(C1-8)alkyl-O—, —O—(C2-8)alkenyl-O—, —O—(C2-8)alkynyl-O—, —C(O)—(C1-8)alkyl-C(O)— (wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are straight carbon chains optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, —C(O)O—(C1-8)alkyl, —C1-8alkyl-C(O)O—(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3((C1-8))alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo; and, wherein any of the foregoing alkyl, alkenyl and alkynyl linking groups are optionally substituted with one to two substituents independently selected from the group consisting of heterocyclyl, aryl, heteroaryl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl, heteroaryl(C1-8)alkyl, spirocycloalkyl and spiroheterocyclyl (wherein any of the foregoing cycloalkyl, heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein any of the foregoing heterocyclyl substituents are optionally substituted with oxo)), cycloalkyl (wherein cycloalkyl is optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), —(O—(CH2)1-6)1-5—O—, —O—(CH2)1-6—O—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—O—(CH2)1-6—O—, —(O—(CH2)1-6)1-5—NR6—, —O—(CH2)1-6—NR6—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—NR6—, —(O—(CH2)1-6)0-5—S—, —O—(CH2)1-6—S—(CH2)1-6—O—, —O—(CH2)1-6—O—(CH2)1-6—S—, —NR6—NR7—, —NR6—(CH2)1-6—NR7—, —N—(CH2)1-6—NR7—(CH2)1-6—NR8—, —NR9—C(O)—, —C(O)—NR9—, —C(O)—(CH2)0-6—NR6—(CH2)0-6—C(O)—, —NR6—(CH2)0-6—C(O)—(CH2)1-6—C(O)—(CH2)0-6—NR7—, —NR6—C(O)—NR7—, —N—C(NR7)—NR8—, —O—(CH2)1-6—NR6—(CH2)1-6—S—, —S—(CH2)1-6—NR6—(CH2)1-6—O—, —S—(CH2)1-6—NR6—(CH2)1-6—S— and —NR6—(CH2)1-6—S—(CH2)1-6—NR7— (wherein R6, R7 and R8 are independently selected from the group consisting of hydrogen, C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, C1-8alkoxy, (C1-8)alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo); and, wherein R8 is selected from the group consisting of C1-8alkyl, C1-8alkoxy(C1-8)alkyl, carboxyl(C1-8)alkyl, amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), hydroxy(C1-8)alkyl, heterocyclyl(C1-8)alkyl, aryl(C1-8)alkyl and heteroaryl(C1-8)alkyl (wherein the foregoing heterocyclyl, aryl and heteroaryl substituents are optionally substituted with one to four substituents independently selected from the group consisting of C1-8alkyl, (C1-8)alkoxy, C1-8alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl; and, wherein heterocyclyl is optionally substituted with oxo)); and,
R1 and R3 are independently selected from the group consisting of hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl (wherein alkyl, alkenyl and alkynyl are optionally substituted with a substituent selected from the group consisting of C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), (halo)1-3, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy, hydroxy(C1-8)alkyl and oxo), C1-8alkoxy, C1-8alkoxycarbonyl, (halo)1-3(C1-8)alkoxy, C1-8alkylthio, aryl, heteroaryl (wherein aryl and heteroaryl are optionally substituted with a substituent selected from the group consisting of C1-8alkyl, C1-8alkoxy, alkoxy(C1-8)alkyl, carboxyl, carboxyl(C1-8)alkyl, amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), amino(C1-8)alkyl (wherein amino is substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), halogen, (halo)1-3(C1-8)alkyl, (halo)1-3(C1-8)alkoxy, hydroxy and hydroxy(C1-8)alkyl), amino (substituted with a substituent independently selected from the group consisting of hydrogen and C1-4alkyl), cyano, halogen, hydroxy and nitro;
and pharmaceutically acceptable salts thereof.

### Claim 13

A compound of Formula (Ia1):
49
wherein R4, R2 and R5 are dependently selected from:
11 R4 R2 R5 —(CH2)2— —O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—O—(CH2)2—O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(Et)—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(Me)—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(i-Pr)—(CH2)2—O— —(CH2)2—; —(CH2)2— —N(Me)—(CH2)2—N(Me)—(CH2)2—N(Me)— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(2-hydroxy-Et)—(CH2)2—O— —(CH2)2—; and, —(CH2)2— —O—(CH2)2—O—(CH2)2—N(Me)— —(CH2)3—.

### Claim 14

A compound of Formula (Ib1):
50
wherein R4, R2 and R5 are dependently selected from:
12 R4 R2 R5 —(CH2)2— —O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—O—(CH2)2—O—(CH2)2—O—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(Et)—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—S—(CH2)2—O— —(CH2)2—; —(CH2)5— —NH— —(CH2)5—; —(CH2)5— —N(Et)— —(CH2)5—; —(CH2)5— —NH— —(CH2)4—; —(CH2)5— —N(Et)— —(CH2)4—; —(CH2)4— -2,6-pyridinyl- —(CH2)4—; —(CH2)4— —C(O)—(CH2)2— —(CH2)4—; —CH2— —CH[R](OH)—(CH2)6—CH[R](OH)— —CH2—; and, —(CH2)2— —O—(CH2)2—O— —(CH2)2—.

### Claim 15

A compound of Formula (Ifl):
51
wherein R4, R2 and R5 are dependently selected from:
13 R4 R2 R5 —(CH2)2— —O—(CH2)2—N(Me)—(CH2)2—O— —(CH2)2—; —(CH2)2— —O—(CH2)2—N(Et)—(CH2)2—O— —(CH2)2—; and, —O—(CH2)2-N(2-OMe—Et)—(CH2)2—O— —(CH2)2— —(CH2)2—.

### Claim 16

A compound of Formula (Iil):
52
wherein R4, R2 and R5 are dependently selected from:
14 R4 R2 R5 —CH2— -1,3-phenyl- —CH2—; and, —CH2— -2,6-pyridinyl- —CH2—.

### Claim 17

A compound of Formula (Ij 1):
53
wherein R4, R2 and R5 are dependently selected from:
15 R4 R2 R5 —(CH2)2— —O—(CH2)2—O— —(CH2)2—; and, —(CH2)2— —O—(CH2)2—O—(CH2)2—O— —(CH2)2—.

### Claim 18 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 19 (depends on 1)

A pharmaceutical composition made by mixing a compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 20 (depends on 1)

A method for preparing a pharmaceutical composition comprising mixing a compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 21 (depends on 1)

A method for treating or ameliorating a kinase mediated disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of claim 1.

### Claim 22 (depends on 21)

The method of claim 21 wherein the disorder is mediated by selective inhibition of a kinase selected from the group consisting of protein kinase C and glycogen synthase kinase-3.

### Claim 23 (depends on 22)

The method of claim 22 wherein the kinase is selected from the group consisting of protein kinase C α, protein kinase C β-II, protein kinase C γ and glycogen synthase kinase-3β.

### Claim 24 (depends on 21)

The method of claim 21 wherein the disorder is mediated by dual inhibition of at least two kinases selected from the group consisting of protein kinase C and glycogen synthase kinase-3.

### Claim 25 (depends on 24)

The method of claim 24 wherein at least two kinases are selected from the group consisting of protein kinase C α, protein kinase C β-II, protein kinase C γ and glycogen synthase kinase-3.

### Claim 26 (depends on 1, 21)

The method of claim 21 wherein the therapeutically effective amount of the compound of claim 1 is from about 0.001 mg/kg/day to about 300 mg/kg/day.

### Claim 27 (depends on 21)

The method of claim 21 wherein the kinase mediated disorder is selected from the group consisting of cardiovascular diseases, diabetes, diabetes-associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and CNS disorders.

### Claim 28 (depends on 27)

The method of claim 27 wherein cardiovascular diseases are selected from the group consisting of acute stroke, heart failure, cardiovascular ischemia, thrombosis, atherosclerosis, hypertension, restenosis, retinopathy of prematurity and age-related macular degeneration.

### Claim 29 (depends on 27)

The method of claim 27 wherein diabetes is selected from the group consisting of insulin dependent diabetes and Type II non-insulin dependent diabetes mellitus.

### Claim 30 (depends on 27)

The method of claim 27 wherein diabetes-associated disorders are selected from the group consisting of impaired glucose tolerance, diabetic retinopathy, proliferative retinopathy, retinal vein occlusion, macular edema, cardiomyopathy, nephropathy and neuropathy.

### Claim 31 (depends on 27)

The method of claim 27 wherein inflammatory diseases are selected from the group consisting of vascular permeability, inflammation, asthma, rheumatoid arthritis and osteoarthritis.

### Claim 32 (depends on 27)

The method of claim 27 wherein immunological disorders are selected from the group consisting of transplant tissue rejection, HIV-1 and PKC modulated immunological disorders.

### Claim 33 (depends on 27)

The method of claim 27 wherein dermatological disorders are selected from the group consisting of psoriasis, hair loss and baldness.

### Claim 34 (depends on 27)

The method of claim 27 wherein oncological disorders are selected from the group consisting of cancer, tumor growth, uncontrolled cell proliferation, proliferative angiopathy and angiogenesis.

### Claim 35 (depends on 27)

The method of claim 27 wherein central nervous system disorders are selected from the group consisting of chronic pain, neuropathic pain, epilepsy, chronic neurodegenerative conditions, dementia, Alzheimer's disease, mood disorders, schizophrenia, manic depression and neurotraumatic, cognitive decline and ischemia-related diseases.

### Claim 36 (depends on 1, 21)

The method of claim 21 further comprising a method for use for a compound of claim 1 as an adjunct to chemotherapy and radiation therapy.

### Claim 37 (depends on 18, 21)

The method of claim 21 further comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition of claim 18.

### Claim 38 (depends on 18, 37)

The method of claim 37 wherein the therapeutically effective amount of a pharmaceutical composition of claim 18 is from about 0.001 mg/kg/day to about 300 mg/kg/day.

### Claim 39 (depends on 35)

The method of claim 35 wherein ischemia-related diseases are those resulting from head trauma or transient ischemic stroke.
